Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Allen

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2019
Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for AzithromycinEllen N Kersh, Vanessa Allen, Eric Ransom, et al.
Journal of Clinical Microbiology|September 5, 2015
Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012Pam Sawatzky, Gary Liu, Jo-Anne R Dillon, et al.
Emerging Infectious Diseases|December 23, 2014
Hospital-associated transmission of Brucella melitensis outside the laboratoryChristopher F Lowe, Adrienne J Showler, Suzette Perera, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 12, 2020
Lack of COVID-19 transmission on an international flightKevin L Schwartz, Michelle Murti, Michael Finkelstein, et al.
BMC Genomics|February 20, 2010
High-throughput genome sequencing of two Listeria monocytogenes clinical isolates during a large foodborne outbreakMatthew W Gilmour, Morag Graham, Gary Van Domselaar, et al.
Antimicrobial Agents and Chemotherapy|January 3, 2022
Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018Pam Sawatzky, Walter Demczuk, Brigitte Lefebvre, et al.
Canadian Family Physician Medecin De Famille Canadien|June 23, 2016
Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistanceDionne Gesink, C Sarai Racey, Christine Seah, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance DeterminantsWalter Demczuk, Irene Martin, Pam Sawatzky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
Diagnosis and Management of First Case of COVID-19 in Canada: Lessons Applied From SARS-CoV-1Xavier Marchand-Senécal, Rob Kozak, Samira Mubareka, et al.
Canadian Journal of Microbiology|October 10, 2013
Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010Irene Martin, Pam Sawatzky, Gary Liu, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2019
Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for AzithromycinEllen N Kersh, Vanessa Allen, Eric Ransom, et al.
Journal of Clinical Microbiology|September 5, 2015
Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012Pam Sawatzky, Gary Liu, Jo-Anne R Dillon, et al.
Emerging Infectious Diseases|December 23, 2014
Hospital-associated transmission of Brucella melitensis outside the laboratoryChristopher F Lowe, Adrienne J Showler, Suzette Perera, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 12, 2020
Lack of COVID-19 transmission on an international flightKevin L Schwartz, Michelle Murti, Michael Finkelstein, et al.
BMC Genomics|February 20, 2010
High-throughput genome sequencing of two Listeria monocytogenes clinical isolates during a large foodborne outbreakMatthew W Gilmour, Morag Graham, Gary Van Domselaar, et al.
Antimicrobial Agents and Chemotherapy|January 3, 2022
Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018Pam Sawatzky, Walter Demczuk, Brigitte Lefebvre, et al.
Canadian Family Physician Medecin De Famille Canadien|June 23, 2016
Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistanceDionne Gesink, C Sarai Racey, Christine Seah, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance DeterminantsWalter Demczuk, Irene Martin, Pam Sawatzky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
Diagnosis and Management of First Case of COVID-19 in Canada: Lessons Applied From SARS-CoV-1Xavier Marchand-Senécal, Rob Kozak, Samira Mubareka, et al.
Canadian Journal of Microbiology|October 10, 2013
Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010Irene Martin, Pam Sawatzky, Gary Liu, et al.
Pageof 4